Galanin receptor
Galanin receptor is a type of G protein-coupled receptor that is activated by the neuropeptide galanin. There are three known subtypes of galanin receptors, known as GAL1, GAL2, and GAL3. These receptors are involved in a variety of physiological and pathological processes, including pain regulation, feeding behavior, and mood regulation.
Structure and Function
Galanin receptors are integral membrane proteins that are composed of seven transmembrane domains. They are coupled to G proteins, which mediate the intracellular responses to galanin binding. The specific responses depend on the subtype of the receptor and the cell type in which it is expressed.
GAL1 is primarily expressed in the central nervous system, and is involved in the regulation of pain and feeding behavior. GAL2 is widely distributed throughout the body and is involved in a variety of functions, including neurotransmission, neuroprotection, and the regulation of mood and cognition. GAL3 is primarily expressed in the peripheral nervous system, and is involved in pain regulation and feeding behavior.
Clinical Significance
Galanin receptors have been implicated in a variety of diseases and disorders. For example, alterations in galanin receptor function have been associated with neuropathic pain, depression, anxiety, epilepsy, and Alzheimer's disease. As a result, these receptors are being investigated as potential therapeutic targets for these conditions.
Research and Therapeutic Potential
Research into the function of galanin receptors and the development of drugs that can modulate their activity is an active area of biomedical research. Several compounds that selectively activate or inhibit galanin receptors have been developed, and some of these have shown promise in preclinical studies. However, further research is needed to fully understand the therapeutic potential of these receptors.
See Also
References
This GPCR-related article is a stub. You can help WikiMD by expanding it.
This article is a neuroscience stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD